[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Home

Learning Objectives
Accreditation
Speaker Biographies


View Video Presentation

Presentation Transcript
Download Slides
Online Quiz

CFR Regulations
Drug Information
FDA Advisory Committees
Orange Book
OTC Fed. Reg. Publications

Technical Support
Contact Us
















 



Online Training Seminar

'Drug Review and Related Activities
in the United States'


Revised September 2004

 Advance to Next Section....

BIOGRAPHIES OF SPEAKERS:

Brenda J. Kiliany, Pharm.D.
Team Leader, Division of Drug Information
Office of Training and Communications
Center for Drug Evaluation and Research
Food and Drug Administration

Brenda Kiliany, Pharm.D., is a Team Leader in the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER), Division of Drug Information. Dr. Kiliany responds to a wide variety of inquiries about human drugs from pharmacists, doctors, other health care professionals, consumers and industry representatives. She writes consumer information and frequently asked questions (FAQs) about recently approved new molecular entities for FDA’s web page.  Additionally, Dr. Kiliany provides an overview of CDER and the new drug approval process to foreign government dignitaries and visiting students. She serves as a preceptor for Pharm.D. students in drug information rotations.

Her previous position with FDA was in the Product Information Management Branch where she was responsible for quality control of the Drug Registration and Listing (DRLS) contract.

Prior to joining FDA, Dr. Kiliany was a pharmacist in the ambulatory care section at the National Institutes of Health (NIH) Clinical Center. While at NIH, she aided in the development and implementation of a warfarin-monitoring clinic in the National Heart Lung and Blood Institute clinic. Dr. Kiliany received her B.S. degree in pharmacy from the University of Pittsburgh and her Pharm.D. degree from the University of Arkansas for Medical Sciences, College of Pharmacy.

Mary E. Kremzner, Pharm.D.
CDR United States Public Health Service (USPHS)
Team Leader, Division of Drug Information
Office of Training and Communications
Center for Drug Evaluation and Research
Food and Drug Administration

CDR Kremzner is a Team Leader in the Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Division of Drug Information.  CDR Kremzner's work involves responding to inquiries from a broad range of sources, including regulated industry, academia, consumers, health care professionals and others.  She also acts as a host for visiting representatives of foreign governments and regularly presents overviews on CDER’s role in drug development and review.  CDR Kremzner also writes consumer friendly information on a variety of drug products for FDA’s web site.

Before joining FDA in 1996, CDR Kremzner worked in a contract capacity to the FDA in CDER’s Product Information Management Branch. CDR Kremzner’s responsibilities included leading a team of pharmacists and technical reviewers in maintaining the FDA’s database created to comply with the Drug Listing Act.

CDR Kremzner began her career working in retail pharmacy for eight years and continues to maintain her skills as a practicing pharmacist by working part-time in community pharmacy.  She received her degrees from the University of Maryland School of Pharmacy.

 Advance to Next Section....
 

 

  


Main FDA number: 1-888-INFO-FDA (1-888-463-6332)
Drug Information Number: 301-827-4570  (8:00 am - 4:30 pm Eastern Time)

 

Page Last Updated: February 2, 2006

 
horizonal rule